We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
French healthcare regulator AFSSAPS is to create a new unit to monitor drug safety after marketing approval has been given, with new checks on promotional material and patient information.
In the wake of soaring drug prices in recent years, China's powerful National Development and Reform Commission (NDRC) is to decentralise the prices of OTC pharmaceuticals.
Biopharmaceutical outsourcing company Parexel International Corp. has acquireda South African pharmacology business for $6 million in cash and additionalpayments based on future performance.
Johnson & Johnson is buying back the European marketing rights to the heart-failuredrug Natrecor from GlaxoSmithKline. Financial terms were not disclosed.
In the wake of South Africa'srecent US$500mn ARVs tender, set to expire in 2007, the level of co-operationwith major multinational manufacturers of HIV/AIDS drugs has continued to increase.